immunohistochemistry (ihc)

Show results for

Unknown (5057)
Genomics (214)
Transcriptomics (173)
Proteomics (66)
Clinical (5)
Other (4)
Genomic (3)
Methylation profiling (3)
Metabolomics (3)
Models (1)

Organisms

Homo sapiens (191)
Schizophyllum commune H4-8 (36)
Mycobacterium tuberculosis SP7 (36)
Oryza sativa Japonica Group (36)
Candidatus Endoriftia persephonae (36)
Mycobacterium tuberculosis SP10 (36)
Mycobacterium tuberculosis SP13 (36)
Mycobacterium tuberculosis SP22 (36)
Chlamydomonas reinhardtii (36)
Pyricularia oryzae P131 (36)
Enterococcus mundtii CRL35 (36)
Oncorhynchus tshawytscha (36)
Pseudomonas canadensis (36)
Strongylocentrotus purpuratus (36)
Influenza A virus (A/California/04/2009(H1N1)) (36)
Homo (36)
Pseudomonas aeruginosa PAO1H2O (36)
Human alphaherpesvirus 1 strain 17 (36)
Quercus petraea (36)
Canis lupus (36)
Mycobacterium tuberculosis SP1 (36)
Marchantia polymorpha subsp. ruderalis (36)
Zymomonas mobilis subsp. mobilis ZM4 = ATCC 31821 (36)
Methylocystis sp. (36)
Mus musculus (30)
Macaca mulatta (2)
Canis lupus familiaris (2)
Rattus norvegicus (2)
Solea senegalensis (1)
Fusarium sinicum (1)

Organisms

Homo sapiens (132)
Mus musculus (20)
Rattus norvegicus (3)
Solea senegalensis (1)
Canis lupus familiaris (1)
Macaca mulatta (1)

Repository

ENA (195)
geo (117)
biostudies-arrayexpress (70)
pride (36)
iProX (21)
EGA (13)
PanoramaPublic (4)
dbGaP (3)
MetaboLights (3)
jPOST (2)
MassIVE (2)
BioModels (1)

Tissue

Brain (8)
Cell culture (4)
Epithelial cell (4)
Breast (3)
Kidney (3)
Liver (3)
Oropharyngeal cancer cell (1)
Kidney field (1)
Neurohypophysis (1)
Neck (1)
Central nervous system neuron (1)
Femoral muscle (1)
Synovium (1)
Corpus luteum (1)
Ovary cancer cell (1)
Myometrium (1)
Tonsil (1)
Tongue (1)
Head (1)
Amyloid plaque (1)
Pyramidal neuron (1)
Ileum (1)
Astrocyte (1)
Lymph node (1)
Uterine endometrium (1)
Microglial cell (1)
Colon (1)
Ovary (1)
Placenta (1)
Spinal cord (1)

Disease

Breast cancer (5)
Alzheimer's disease (2)
Non-small cell lung carcinoma (1)
Myelolipoma (1)
Mesothelioma (1)
Colorectal Neoplasms, Hereditary Nonpolyposis (1)
Colorectal neoplasms malignant (1)
Rectal Cancer (1)
Colorectal cancer (1)
Colorectal Neoplasms (1)
Endometrioid ovary carcinoma (1)
Limb ischemia (1)
Rhabdoid cancer (1)
Oral squamous cell carcinoma (1)
Ovarian cancer (1)
Head and neck cancer (1)
Wilson disease (1)
Neurodegenerative disease (1)
Ovarian serous carcinoma (1)
Rheumatoid arthritis (1)
Osteosarcoma (1)
Crohn's disease (1)
Disease free (1)
Chronic kidney disease (1)
Colon cancer (1)
Human papillomavirus infectious disease (1)

Technology Type

Mass Spectrometry (36)
Shotgun proteomics (17)
Bottom-up proteomics (11)
Data-dependent acquisition (4)
Data-independent acquisition (4)
SWATH MS (3)
Mass spectrometry assay (2)
Gel-based experiment (2)
Top-down proteomics (2)
Affinity purification coupled with mass spectrometry proteomics (2)
Mass spectrometry (1)
Mass spectrometry imaging (1)
DiaPASEF (1)

Instrument Platform

Liquid Chromatography MS - positive - reverse-phase (2)
Liquid Chromatography MS - negative - reverse-phase (2)
Dr. Tom Multi-omics Data Mining System (1)
Animal Experiment Facility (1)
SPF Animal Room (1)
PCR Thermocycler, Fragment Analyzer (1)
Centrifuge, Nucleic Acid Quantification Instrument (1)
Biosafety Cabinet, Liquid Nitrogen Tank, -80°C Freezer (1)
DNBSEQ-T7 (1)
NextSeq 500 (1)
TripleTOF 6600 (1)
Q Exactive HF-X (1)
Liquid Chromatography MS - alternating - reverse phase (1)

Publication Date

2025 (30)
2024 (28)
2022 (19)
2021 (18)
2026 (17)
2023 (15)
2015 (15)
2012 (13)
2013 (12)
2011 (12)
2010 (11)
2016 (10)
2020 (10)
2009 (9)
2008 (9)
2014 (6)
2019 (5)
2018 (5)
2007 (4)
2017 (3)
2006 (1)

UNIPROT ID/AC

Q9UK32 (1)
Q9H665 (1)
O00443 (1)
Q504U8 (1)
P31751 (1)
P27361 (1)
P62070 (1)
Q07889 (1)
Q02750 (1)
P04049 (1)

CHEBI ID

CHEBI:17084 (1)

Metabolite Name

ME0117874 (1)
ME0131010 (1)
ME0128050 (1)
ME0014756 (1)
ME0115402 (1)
ME0128038 (1)
ME0162447 (1)
ZINC95912369 (1)
ME0166726 (1)
ME0148637 (1)
ME0153234 (1)
ZINC38256655 (1)
ME0142756 (1)
ME0163862 (1)
FDATN01122 (1)
ME0143548 (1)
ME0163301 (1)
ME0159371 (1)
ME0161995 (1)
ME0168294 (1)
ME0155248 (1)
ME0144105 (1)
ZINC85911136 (1)
ME0161855 (1)
ME0116271 (1)
ZINC13340428 (1)
ME0156087 (1)
ZINC85493085 (1)
ME0166217 (1)
ME0142617 (1)

First Public Date

2025 (32)
2024 (30)
2014 (29)
2023 (20)
2021 (18)
2026 (15)
2022 (14)
2020 (7)
2017 (7)
2015 (7)
2019 (6)
2018 (6)
2016 (3)
2013 (1)

Modelling Approach

Ordinary differential equation model (1)

Study status

Ongoing (1)
Not provided (1)
Completed (1)
Recruiting (1)
Not yet recruiting (1)

Lab affiliation

Baylor College of Medicine (2)
associate professor of neurology Institute for cell engineering Johns hopkins university school of medicine (1)
Stress- and Immunoproteomics Group, Molecular and Applied Microbiology Department, Leibniz Institute for Natural Product Research and Infection Biology - Hans Knöll Institute Jena (1)
Translational gastroenterology, GIGA institute, University of Liege ULiege Belgium and Hepatogastro entreology and digestive oncology University hospitalof Liège, CHU Liège (1)
Department of Biochemistry, Siebens Drake Research Institute, Western University (1)
Department of Laboratory Medicine and Pathology, Mayo Clinic, 200 First ST SW, Rochester, MN 55905, USA (1)
PD Dr. Oliver Schilling Heisenberg Fellow Institute of Molecular Medicine and Cell Research University of Freiburg Stefan-Meier-Str. 17, Room 02 027 D-79104 Freiburg, Germany +49 761 203 9615 oliver.schilling@mol-med.uni-freiburg.de (1)
Department of Orthopaedics, General Hospital of Ningxia Medical University, Yinchuan, Ningxia, China (1)
Professor, Deputy Head of Centre Novo Nordisk Foundation Center for Protein Research University of Copenhagen DENMARK (1)
Department of Comparative Medicine, Laboratory Animal Center, Dalian Medical University, Dalian, Liaoning 116000, P.R. China (1)
ProCan®, Children’s Medical Research Institute, Faculty of Medicine and Health, The University of Sydney, Westmead, NSW, Australia (1)
Professor, Head of Cancer Research, University of Southern Denmark (1)
Department of Clinical Sciences, Cornell University, 930 Campus Rd, Ithaca, NY, 14853, USA (1)
Section Mass Spectrometry and Proteomics, University Medical Center Hamburg-Eppendorf, Hamburg, Germany (1)
Professor and Deputy Director, Centre for Systems Biology and Molecular Medicine, Yenepoya Research Center, Yenepoya (Deemed to be University), Mangalore 575018, India (1)
Clinical Proteomics Mass Spectrometry, Department of Oncology-Pathology, Science for Life Laboratory and Karolinska Institutet, Stockholm, Sweden (1)
Chronic Disease Programme (UFIEC), Instituto de Salud Carlos III, Majadahonda, E-28220 Madrid, Spain. (1)
QTAS, or previously DMPK, Abbvie Bioresearch Center (1)
Department of Applied Chemistry, Institute of Natural Science, Global Center for Pharmaceutical Ingredient Materials, Kyung Hee University, Yongin, Republic of Korea; Department of Biomedical Science and Technology, Kyung Hee Medical Science Research Institute, Kyung Hee University, Seoul, Republic of Korea. (1)
Department of Molecular and Cellular Neurobiology, Center for Neurogenomics and Cognitive Research, Amsterdam Neuroscience, VU University Amsterdam, The Netherlands (1)
Emory Univerity (1)
Oncoprot Platform, TBM-Core US 005, F-33000 Bordeau, France. univ. Bordeaux, Inserm UMR1312 BoRdeaux Institute of onCology (BRIC), F-33000 Bordeaux, France (1)
Manager, Biological Mass Spectrometry CORE (1)
Fondazione Pisana per la Scienza ONLUS (1)
Graduate Institute of Anatomy and Cell Biology, College of Medicine, National Taiwan University. Taipei, Taiwan (1)
Fondazione Pisana per la Scienza ETS (1)
Director, Advanced Clinical Biosystems Research Institute (1)
Translational Technologies and Bioinformatics, Pharmaceutical Sciences, Roche Pharma Research & Early Development (pRED), Roche Innovation Center Basel, F. Hoffmann-La Roche AG, Grenzacherstrasse 124, CH-4070 Basel, Switzerland (1)
Fondazione Pisana per la Scienza ONLUS, 56017 San Giuliano Terme (PI), Italy (1)
Manager, Biological Mass Spectrometry Core (1)

Keyword

Temozolomide (1)
Mismatch repair (1)
Next-generation sequencing (1)
Microsatellite instability (1)
Intestinal microbiome (1)
Postoperative complications (1)
Immunohistochemistry (1)
Mechanical bowel preparation (1)
Anastomotic leakage (1)

IsPrivate

False (1)

Study type

Transcription profiling by array (54)
Comparative genomic hybridization by array (9)
Observational (3)
Methylation profiling by array (2)
RNA-seq of coding RNA (2)
Interventional (2)
RNAi profiling by array (1)
Proteomic profiling by array (1)
RNA-seq of total RNA (1)

Release Date

2022 (711)
2025 (698)
2023 (633)
2021 (606)
2024 (547)
2020 (409)
2019 (322)
2018 (228)
2016 (202)
2017 (193)
2015 (131)
2014 (125)
2013 (79)
2012 (64)
2026 (61)
2010 (34)
2011 (31)
2009 (23)
2008 (13)
2007 (6)
2006 (5)
2005 (3)
1999 (2)
2002 (1)

Location

Italy (2)
New Zealand (1)
China (1)
France (1)

Previous page
1 / 553
You're on page 1
page 2
page 3
page 4
page 5
page ...
page 553
Next page

Sort by:

Relevance

Page size

Development of an automated PD-L1 immunohistochemistry (IHC) assay for non-small cell lung cancer.

Not available

S-EPMC4561627 | biostudies-literature

High-resolution proteomic analysis of medulloblastoma clinical samples identifies therapy resistant subgroups and MYC immunohistochemistry as a powerful outcome predictor

While international consensus and the 2021 WHO classification recognize multiple molecular medulloblastoma subgroups, these are difficult to identify in current clinical practice. As a result, biology driven risk stratification and therapy assignment for medulloblastoma constitutes a major challenge...

ORGANISM(S): Homo sapiens (Human)

2026-02-23 | PXD051235 | Pride

Identification of proteomic markers in head and neck cancer using MALDI-MS Imaging, LC-MS/MS and IHC

Purpose The heterogeneity of squamous cell carcinoma tissue complicates diagnosis and an individualized therapy to a great extent. Therefore it is of utmost importance to spatially characterize this tissue heterogeneity and to identify appropriate biomarkers. Matrix assisted laser desorption/ionizat...

ORGANISM(S): Homo sapiens (Human)

2018-11-14 | PXD009144 | Pride

Cancer Maldi-ms imaging Immunohistochemistry Biomarker Lc-ms/ms

High-resolution proteomic analysis of medulloblastoma clinical samples identifies therapy resistant subgroups and MYC immunohistochemistry as a powerful outcome predictor

ORGANISM(S): Homo sapiens (Human)

2025-03-06 | PXD051319 | Pride

Medulloblastoma Dia Proteomics Myc Immunohistochemistry

A novel automated IHC staining system for quality control application in ALK immunohistochemistry testing.

Not available

S-EPMC11864879 | biostudies-literature

SRRM4 Expression and the Loss of REST Activity May Promote the Emergence of the Neuroendocrine Phenotype in Castration-Resistant Prostate Cancer

The neuroendocrine (NE) phenotype is associated with the development of metastatic castration-resistant prostate cancer (CRPC). Our objective was to characterize the molecular features of the NE phenotype in CRPC. Expression of chromogranin A (CHGA), synaptophysin (SYP), androgen receptor (AR), and ...

ORGANISM(S): Homo sapiens

2015-06-24 | E-GEOD-66187 | biostudies-arrayexpress

Metallothionein immunohistochemistry has high sensitivity and specificity for detection of Wilson disease

Diagnosis of Wilson disease (WD) can be difficult because of its protean clinical presentation, but early diagnosis is important because effective treatment is available and can prevent disease progression. Using quantitative proteomics, we characterized proteins that are differentially expressed in...

ORGANISM(S): Homo sapiens (Human)

2023-04-18 | PXD029069 | Pride

Quantitative proteomics Immunohistochemistry Liver Wilson disease Mt1g Sensitivity Metallothionein-1g Specificity

A machine learning algorithm for simulating immunohistochemistry: development of SOX10 virtual IHC and evaluation on primarily melanocytic neoplasms.

Not available

S-EPMC10811656 | biostudies-literature

Conventional histological and cytological staining with simultaneous immunohistochemistry enabled by invisible chromogens.

Not available

S-EPMC9042701 | biostudies-literature

Quantitative immunohistochemistry (IHC) analysis of biomarker combinations for human esophageal squamous cell carcinoma.

Not available

S-EPMC8339853 | biostudies-literature

Previous page
1 / 553
You're on page 1
page 2
page 3
page 4
page 5
page ...
page 553
Next page

Sort by:

Relevance

Page size

5529 Results

Show results for

Organisms

Organisms

Repository

Tissue

Disease

Technology Type

Instrument Platform

Publication Date

UNIPROT ID/AC

CHEBI ID

Metabolite Name

First Public Date

Modelling Approach

Study status

Lab affiliation

Tags

Keyword

IsPrivate

Study type

Release Date

Location

OmicsDI is part of the ELIXIR infrastructure

Tweets